Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit
- PMID: 34059219
- PMCID: PMC7170801
- DOI: 10.1016/j.medine.2019.10.008
Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit
Abstract
Objective: To describe the characteristics and evolution of patients with bronchiolitis admitted to a pediatric intensive care unit, and compare treatment pre- and post-publication of the American Academy of Pediatrics clinical practice guide.
Design: A descriptive and observational study was carried out between September 2010 and September 2017.
Setting: Pediatric intensive care unit.
Patients: Infants under one year of age with severe bronchiolitis.
Interventions: Two periods were compared (2010-14 and 2015-17), corresponding to before and after modification of the American Academy of Pediatrics guidelines for the management of bronchiolitis in hospital.
Main variables: Patient sex, age, comorbidities, severity, etiology, administered treatment, bacterial infections, respiratory and inotropic support, length of stay and mortality.
Results: A total of 706 patients were enrolled, of which 414 (58.6%) males, with a median age of 47 days (IQR 25-100.25). Median bronchiolitis severity score (BROSJOD) upon admission: 9 points (IQR 7-11). Respiratory syncytial virus appeared in 460 (65.16%) patients. The first period (2010-14) included 340 patients and the second period (2015-17) 366 patients. More adrenalin and hypertonic saline nebulizations and more corticosteroid treatment were administered in the second period. More noninvasive ventilation and less conventional mechanical ventilation were used, and less inotropic support was needed, with no significant differences. The antibiotherapy rate decreased significantly (p=0.003).
Conclusions: Despite the decrease in antibiotherapy, the use of nebulizations and glucocorticoids in these patients should be limited, as recommended by the guide.
Objetivo: Describir las características y la evolución de los pacientes con bronquiolitis ingresados en una unidad de cuidados intensivos pediátricos. Comparar el tratamiento administrado pre y pospublicación de la guía de práctica clínica de la Academia Americana de Pediatría.
Diseño: Estudio descriptivo y observacional realizado entre septiembre de 2010 y septiembre de 2017.
Configuración: Unidad de cuidados intensivos pediátricos.
Pacientes: Menores de un año con bronquiolitis grave.
Intervenciones: Se compararon 2 períodos (2010-14 y 2015-17), antes y después de la modificación del protocolo de manejo de la bronquiolitis en el hospital, según las guías de la Academia Americana de Pediatría.
Principales variables: Sexo, edad, comorbilidades, gravedad, etiología, tratamiento administrado, infecciones bacterianas, soporte respiratorio e inotrópico, estancia y mortalidad.
Resultados: Se recogieron 706 pacientes, 414 (58,6%) varones, con una mediana de edad de 47 días (RIC 25-100,25). Mediana de escala de gravedad de bronquiolitis (BROSJOD) al ingreso: 9 puntos (RIC 7-11). La etiología por virus respiratorio sincitial se dio en 460 (65,16%) pacientes. El primer período (2010-14) incluyó 340 pacientes y el segundo (2015-17), 366 pacientes. En el segundo período se administraron más nebulizaciones de adrenalina y suero salino hipertónico, y más tratamiento con corticoides. Se usó más ventilación no invasiva y menos ventilación mecánica convencional y precisaron menos soporte inotrópico, sin diferencias significativas. La tasa de antibioterapia disminuyó de forma estadísticamente significativa (p = 0,003).
Conclusiones: Pese a la disminución en la antibioterapia, se debería limitar la utilización de nebulizaciones y corticoides en estos pacientes, como recomienda la guía.
Keywords: Acute respiratory failure; Bronchiolitis; Bronquiolitis; Cuidados intensivos; Insuficiencia respiratoria aguda; Intensive care; Pediatrics; Pediatría.
Copyright © 2019 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.
Figures

Similar articles
-
Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit.Med Intensiva (Engl Ed). 2021 Jun-Jul;45(5):289-297. doi: 10.1016/j.medin.2019.10.006. Epub 2019 Dec 28. Med Intensiva (Engl Ed). 2021. PMID: 31892419 Free PMC article. English, Spanish.
-
Respiratory and pharmacological management in severe acute bronchiolitis: Were clinical guidelines not written for critical care?Arch Pediatr. 2021 Feb;28(2):150-155. doi: 10.1016/j.arcped.2020.11.007. Epub 2020 Dec 16. Arch Pediatr. 2021. PMID: 33339722
-
Risk factors and incidence of invasive bacterial infection in severe bronchiolitis: the RICOIB prospective study.BMC Pediatr. 2022 Mar 17;22(1):140. doi: 10.1186/s12887-022-03206-4. BMC Pediatr. 2022. PMID: 35300645 Free PMC article.
-
The infant with severe bronchiolitis: from high flow nasal cannula to continuous positive airway pressure and mechanical ventilation.Minerva Pediatr. 2018 Dec;70(6):612-622. doi: 10.23736/S0026-4946.18.05358-6. Epub 2018 Oct 18. Minerva Pediatr. 2018. PMID: 30334625 Review.
-
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age.Cochrane Database Syst Rev. 2020 Dec 14;12(12):CD012965. doi: 10.1002/14651858.CD012965.pub2. Cochrane Database Syst Rev. 2020. PMID: 33316083 Free PMC article.
Cited by
-
Patterns of Use of β-2 Agonists, Steroids, and Mucoactive Medications to Treat Bronchiolitis in the PICU: U.S. Pediatric Health Information System 2009-2022 Database Study.Pediatr Crit Care Med. 2025 Mar 1;26(3):e294-e303. doi: 10.1097/PCC.0000000000003670. Epub 2024 Dec 17. Pediatr Crit Care Med. 2025. PMID: 40048297
-
3% nebulized hypertonic saline versus normal saline for infants with acute bronchiolitis: A systematic review and meta-analysis of randomized controlled trials.Medicine (Baltimore). 2022 Oct 28;101(43):e31270. doi: 10.1097/MD.0000000000031270. Medicine (Baltimore). 2022. PMID: 36316926 Free PMC article.
References
-
- Meissner H.C. Viral bronchiolitis in children. N Engl J Med. 2016;374:62–72. - PubMed
-
- Chkhaidze I., Zirakashvili D. Acute viral bronchiolitis in infants. Georgian Med News. 2017;264:43–50. - PubMed
-
- Smith D.K., Seales S., Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician. 2017;95:94–99. - PubMed